Vimarsana
Biggest News Aggregation in the World

Page 18 - Affinity Technologies Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Affinity Technologies Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Affinity Technologies Inc Today - Breaking & Trending Today

WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit - Vimarsana News

WallachBeth Capital Announce Pricing Of bioAffinity Technologies IPO At $6.125 Per Unit

/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bio-Affinity...

bioAffinity Technologies, Inc. (BIAF) to Raise $10 Million in IPO - Vimarsana News

bioAffinity Technologies, Inc. (BIAF) to Raise $10 Million in IPO

BioAffinity Technologies, Inc. (BIAF) plans to raise $10 million in an IPO on Tuesday, May 31st, IPO Scoop reports. The company will be issuing 1,500,000 shares at a price of $6.75 per share. WallachBeth Capital acted as the underwriter for the IPO. bioAffinity Technologies, Inc. provided the following description of their company for its IPO: […]

bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Comme - Vimarsana News

bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Comme

Search jobs 04-Feb-2021 bioAffinity Technologies Executes Agreement with Fosun Long March to Evaluate CyPath® Lung for Commercialization in China China’s leading healthcare company to evaluate bioAffinity’s non-invasive, highly accurate test for early-stage lung cancer with aim to commercialize in world’s largest market SAN ANTONIO--(BUSINESS WIRE)--#TCPP--Shanghai Fosun Long March Medical Science Co., Ltd. (Fosun Long March) has executed a non-binding Letter of Intent (LOI) with bioAffinity Technologies, Inc. providing for Fosun to evaluate...